Commercial Launch Of Fully Bioabsorbable Stent Still Several Years Out

Abbott Vascular says it will approach FDA to design a U.S. clinical trial for its bioabsorbable everolimus-eluting stent once it gets data from a few hundred more patients in its overseas trials